A25 – Spotlight on Complementary Medicines MMDR Reforms

This presentation from key TGA personnel will provide an overview of the status of reform initiatives arising from the Review of Medicines and Medical Devices Regulation relevant to OTC & Complementary Medicines.  This will be a must-attend session for stakeholders impacted by the design of the new regulatory arrangements.

Chairperson: Dr Mariana Gebara-Coghlan, Regulatory Affairs Manager, AbbVie